Chemed Corp: Form 10-Q for the period ended Jun 30, 2016
Filed with the SEC on Jul 29, 2016 and accepted by EDGAR at Jul 29, 2016, 08:28 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-04-01 to 2016-06-30 | $390.4m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2016-01-01 to 2016-06-30 | $780.8m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2016-04-01 to 2016-06-30 | $276.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2016-01-01 to 2016-06-30 | $554.7m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2016-04-01 to 2016-06-30 | $62.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2016-01-01 to 2016-06-30 | $121.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-04-01 to 2016-06-30 | $38.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2016-01-01 to 2016-06-30 | $82.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-04-01 to 2016-06-30 | $971.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2016-01-01 to 2016-06-30 | $1.8m | us-gaap:InterestExpense |
| Income tax | 3 months2016-04-01 to 2016-06-30 | $15.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2016-01-01 to 2016-06-30 | $31.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-04-01 to 2016-06-30 | $24.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2016-01-01 to 2016-06-30 | $49.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-04-01 to 2016-06-30 | $1.48 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2016-01-01 to 2016-06-30 | $2.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-04-01 to 2016-06-30 | $1.51 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2016-01-01 to 2016-06-30 | $3.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-04-01 to 2016-06-30 | 16,831,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2016-01-01 to 2016-06-30 | 16,999,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2016-01-01 to 2016-06-30 | $73.4m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months2016-01-01 to 2016-06-30 | $20.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2016-01-01 to 2016-06-30 | $8.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2016-01-01 to 2016-06-30 | $94.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2016-06-30 | $17.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-06-30 | $147.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-06-30 | $853.0m | us-gaap:Assets |
| Current liabilities | At period end2016-06-30 | $167.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-06-30 | $391.4m | us-gaap:Liabilities |
| Long-term debt | At period end2016-06-30 | $140.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2016-06-30 | $7.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2016-06-30 | $461.6m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2016-06-30 | 16,190,702 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-16-006319. Last ingested by Listed: Nov 5, 2026, 15:55 ET. Listed shows no prices and gives no investment advice.